0.0001USD0.00%Mkt Cap: 5451 USDP/E: —Last update: 2026-05-22
Better Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company's lead product candidate is BT-001, a…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Company
Market Cap5.45K USD
Enterprise Value7.71M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-39.76M USD
Revenue/Share—
Last Price0.0001 USD
Fiscal Year EndDec 2022
MR QuarterSep 2023
Employees54
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.00
PEG—
EV/EBITDA-0.26
EV/Revenue—
P/S—
P/B-0.00
EPS (TTM)-1.10
EPS (Forward)-1.00
52W Range
0.00010% of range0.0010
52W High0.0010 USD
52W Low0.0001 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE4422.69%
ROA-173.30%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-28.93M USD
CapEx (TTM)1.18M USD
FCF Margin—
FCF Yield-285461.38%
Net Debt7.71M USD
Net Debt/EBITDA-0.26
Balance Sheet
Debt/Equity-16.55
Current Ratio0.57
Quick Ratio0.52
Book Value/Sh-0.2450 USD
Cash/Share0.1390 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.54.52M
Float30.54M
Insiders0.00%
Institutions0.01%
Short Interest
Short Ratio0.9d
Short % Float6.21%
Short % Out.3.90%
Shares Short2.13M
Short (prev mo.)960.69K
Technical
SMA 500.0001 (-7.4%)
SMA 2000.0001 (-3.4%)
Beta-39.04
S&P 52W Chg28.31%
Avg Vol (30d)5.83K
Avg Vol (10d)8.71K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—